Introduction

48
Olive oil has been consumed by humans for millennia and is frequently 49 associated with health-related properties. The Mediterranean diet and olive oil 50 consumption in particular are correlated with lower cancer incidence and mortality (1-3).
51
A meta analyses of nineteen observational studies performed between 1990 and 2011 52 that included approximately 35,000 individuals found that olive oil intake is inversely 53 related to cancer prevalence (4). More recently, a randomized trial found that women 54 who adhered to a Mediterranean diet supplemented with extra virgin olive oil (EVOO) 55 had 62% less invasive breast cancer incidence than a control group that was advised to 56 restrict dietary fats (5). These studies, however, did not distinguish between the 57 protective effects of EVOO's triglycerides and its phenolic components. Furthermore, to 58 the best of our knowledge, no controlled study tested the effect of high phenolic EVOO 59 on cancer. (6). A few years later, it was reported to be the primary agent that conveys strong 63 stinging sensation at the back of the throat when ingesting certain EVOOs (7). In 2005, 64 Beauchamp and colleagues published the first paper to refer to this compound as 
86
The proposed mechanisms for oleocanthal activity differ among the different research 87 groups. El Sayed and colleagues published several papers illustrating that oleocanthal 88 acts a c-Met inhibitor (12, 14, 18 
Antibodies
148
Mouse anti human galectin-3 antibody (BD Bioscineces, 556904), goat anti-human weeks of age to calculate how much working solution (2.5 µg/µl) to make in normal 228 0.9% saline and the same dose was used for that week. Kaplan-Meier survival curve 229 was generated using GraphPad Prism. The pancreases of treated mice at 14 weeks of 230 age were dissected, and macroscopic tumors (> 0.5 mm 3 ) were counted and measured.
231
Tumor volume (v) was calculated using the formula for a spheroid: v = 0.52 x (width) 2 x 232 (length). All the tumor volumes from each mouse were summed up as the tumor (Fig 1B) -indicating that the cell death induced by oleocanthal is rapid.
266
We previously reported that oleocanthal-induced cell death is due to a necrotic 267 mechanism, whereas other groups have reported the mechanism of death to be 268 apoptotic (15, 16).
269
To further establish the mechanism of cell death, we performed a well- (Fig 2A) . The translocation of galectin-3 from stability as compared to vehicle (Fig 2D) . This indicates that oleocanthal does not act 342 directly as a membrane disrupting agent on lysosomes, but rather induces lysosomal 343 permeability only in a cellular context -likely through oleocanthal metabolites.
344
The heat shock protein HSP70 is known to stabilize lysosomal membranes (28) 345 and in various models of LMP, HSP70 provides protection from subsequent cell death 346 (38). We, therefore, overexpressed HSP70 in PC3 prostate cancer cells and examined 347 the effect on oleocanthal-induced loss of cell viability. Indeed, oleocanthal-induced loss 348 of cell viability was partially rescued by HSP70 overexpression (Fig 2E) , further closely mimic those found in human pancreatic neuroendocrine tumorigenesis (i.e., 388 hyperplasia, angiogenesis, adenoma, and invasive carcinoma) (39). We treated mice 389 with 5 mg/kg oleocanthal or DMSO vehicle daily through intraperitoneal injection starting 390 at 9 weeks of age. The median survival of vehicle-treated mice was 14 weeks of age 391 (Fig 3A) . In contrast, the oleocanthal-treated animals had a significant extension of life (Fig 3B) .
399
To determine whether the tumors were smaller due to LMP induced cell death, oil, and corn oil were determined by 1H-NMR as described in Materials and Methods
426
( Fig 4A) . Two EVOOs (Colavita EVOO, and Olive Ranch) had average content of 427 oleocanthal. Two EVOOs (The Governor and Atsas) had levels of oleocanthal that was 428 5 or 6-fold higher than the other EVOOs. The non-virgin olive oil (Colavita mild) and the 429 corn oil (Mazola) had no detectable oleocanthal and were used as negative controls.
430
We then prepared cellular treatment media that consisted of cell culture media and 431 EVOO in a ratio of 25:1. We used this specific ratio because it would make the Fig 4B) and MDA-MB-231 breast cancer cells (Fig 4D) with this enriched media. We also analyzed the ability of EVOO to induce LMP as determined by cathepsin (Fig 4C) and MDA-MB-231 cells (Fig 4E) . In contrast, the other 448 oils caused minimal cytosolic cathepsin release -indicating that the oleocanthal content 449 in EVOOs is a major determinant for EVOO's cancer-protective properties. These data 450 demonstrate that oleocanthal is able to exert this beneficial effect when delivered via 451 whole EVOO and not only in a purified phenolic form. In addition to looking into the effects of purified oleocanthal, we were very 500 interested to see if oleocanthal in a more natural form can cause a similar outcome. no oleocanthal had no effect on cell viability. Furthermore, by looking at cytosolic 513 cathepsin release, the EVOOs mechanism of promoting cancer cell death also involved 514 LMP, similar to the effects of purified oleocanthal.
515
Many studies have linked consumption of EVOO with reduced incidence of 516 cancer (4), most significantly a randomized trial in which elevated EVOO in the diet led 517 to a 62% reduction in the incidence of breast cancer in Spain over a 5 year period (5). 
529
Whether purified oleocanthal could be used therapeutically remains to be evaluated.
530
How can one determine whether there are high levels of oleocanthal in an EVOO? 
